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Successful treatment with indomethacin of three children with
Bartter's syndrome. F. Bonnici. Endocrine-Metabolic Service,
Department of Paediatrics, Groote Schuur Hospital, and Uni-
versity of Cape Town, South Africa. Three children with Bail-
ter's syndrome were treated for 9 to 18 months with indometha-
cm to inhibit the production of prostaglandins which seem to
play a central part in the pathogenesis of the disease. Clinical
symptoms, hypokalemia, alkalosis, hyperreninemia, and hyper-
aldosteronuria were corrected. Reversal of the insensitivity to
angiotensin infusion was demonstrated in one child. A remark-
able catch-up growth occurred in all. An attempt to substitute
aspirin for indomethacin in one child led to severe hypokalemic
alkalosis (serum potassium, 0.6 mmoles/liter; pH, 7.66) with
marked hypercapnia and respiratory depression. Intravenous ad-
ministration of arginine monochloride corrected the metabolic al-
kalosis and restored normal ventilation. Inhibition of prostaglan-
din synthesis has been shown to be the only therapy capable of
maintaining normokalemia for prolonged periods in Bartter's
syndrome at the expense, however, of a fall in creatinine clear-
ance.
Clinicopathologic features of the nephrotic syndrome in South
African children. H. M. Coovadia, M. A. Adhikari, and L. Morel
Maroger. Department of Paediatrics and Child Health, Univer-
sity of Natal, Medical School, Congella, Durban, South Africa.
We have investigated the etiology, natural history, and response
to treatment of the nephrotic syndrome in African and Indian
children. A total of 130 children, of whom 74 were Africans and
56 were Indians with biopsy-proven nephrotic syndrome, were
studied and followed up for periods of 3 months to 12 years.
Most (86%) of the Africans had obvious glomerular lesions,
whereas 75% of Indians had minimal change. Extramembranous
and proliferative lesions accounted for most of the histologic
types in Africans. The disease in Indian children was similar to
that in other countries in age of onset, sex distribution, histologic
pattern, and steroid responsiveness. Africans differed from chil-
dren in other continents in frequency of histologic categories,
steroid responsiveness, and occasionally in clinical behavior.
They were also different from children in tropical Africa in show-
ing a lower incidence of the disease, male dominance, and ab-
sence of malarial nephropathy. Etiology in nearly all children re-
mains unidentified.
Porphyrin in renal failure. R. S. Day and L. Eales. Department
of Medicine, University of Cape Thwn, Medical School, Obser-
vatory, South Africa. There have been very few studies of the
porphyrin status in chronic renal failure, and these have been
based on conventional solvent-extraction techniques. In this pa-
per we report our experience with a recently developed, highly
sensitive, thin-layer chromatographic fluoroscanning technique
which has been applied to the study of undialyzed and dialyzed
patients with chronic renal failure. Individual porphyrins in ex-
creta, blood, and dialysate were clearly distinguished and quan-
titated by fluoroscanning after separation by using thin-layer
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chromatography (TLC). Porphyrin isomers are identified with
high performance liquid chromatography (HPLC). RBC pro-
toporphyrin was often elevated, whereas total stool porphyrins
were depressed by approximately 50% (P <0.01) compared with
normal subjects. Plasma uroporphyrin concentration was always
elevated, whereas coproporphyrin and protoporphyrin were ab-
sent or well below normal plasma concentrations. Uroporphyrin
was the main urinary porphyrin, with only trace amounts of
coproporphyrin detected. Dialysate concentrations were gener-
ally porphyrin-free. The anemia of varying degrees usually asso-
ciated with renal failure probably explains the observed elevated
RBC protoporphyrin. Unless hepatic porphyrin synthesis is
drastically altered in patients on hemodialysis, the abnormal por-
phyrin constituents detected in their stool, urine, and plasma in-
dicate that the kidney is the source of urinary coproporphyrin in
normal subjects.
Psychiatric and sociocultural study of 12 black patients at Ba-
ragwanath Hospital referred from the Renal Unit for assessment
for renal transplantation. E. D. Freed, E. Bishop, and E. N.
Khumalo. Hi/Ibrow, S. Africa. The aims of the study were to
determine the psychiatric and sociological status as well as cul-
tural influences in the patients' reaction to end-stage renal fail-
ure, dialysis, and renal transplantation. The patients were as-
sessed during 1978 by clinical interview of a semistructured type.
Information was obtained from the patients and the Renal Unit
sister-in-charge relating to age, sex, marital status, occupation,
composition of household, presence of financial or social prob-
lems, and attitudes to their illness. There were 8 females and 4
males (average age, 35.75 years). Eight were married, 1 wid-
owed, 1 divorced, and 2 single. All lived with their families or a
caring person. Cultural problems were related to initial problems
with diet and an initial resistance to donating or receiving organs.
These problems were overcome by an educational program.
Apart from the two cases of endoreactive depression, there was
a remarkable absence of psychiatric symptomatology. Initial cul-
tural problems in coping, understanding, and cooperating with
the dialysis and transplant program were handled by an educa-
tional program carried out by the Renal Unit.
Unsafe automatic peritoneal dialysis in Johannesburg. K. I. Fur-
man, H. J. Koornhof, K. Frizelle, C. Block, H. van Wyk, and E.
R. Allcock. Renal Unit, Johannesburg Hospital, Depart nents of
Pharmacology and Microbiology, University of the Witwaters-
rand and the Quality Control Department of Kea grams Ltd.,
South Africa. A microbiologic study on four PDS-300 automated
dialyzers installed in the Peritoneal Dialysis Unit of the Johan-
nesburg Hospital was undertaken to ascertain the cause of an
increasing incidence of peritonitis. High bacterial counts,
Pseudomonas bacteria, and endotoxins were found in the outflow
from plastic pipes that delivered the main water supply, and to a
greater extent in the outflow of water softeners interposed be-
tween the main water supply and the PDS machines. Following
formalin sterilization and rinsing procedures, endotoxins could
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still be detected in the permeate from the RO modules and in the
dialysate deliveries. Disassembly of the RO modules revealed
thick deposits of slime composed of bacteria and inorganic debris
that had collected on the surfaces of the RO membranes. Imper-
fect 0-ring seals within the assemblies were noted as being pos-
sible sites for admixture of permeate and reject water. As a result
of this study, the water softeners were removed from the cir-
cuits, prefilters of 25-ti. caliber were replaced by 5-'u. filters, and
new RO modules designed to prevent admixture of permeate and
reject water were fitted. When the modifications were com-
pleted, the dialysate deliveries were retested and found to be free
of bacteria and endotoxins, and the machines were put back into
dialyzing service. After 1 month of continuous use, however, at-
tacks of peritonitis in the patients began to recur with increasing
frequency. Once again endotoxins were found to be present in
the dialysate deliveries. During the month that followed the mod-
ifications, heavy deposits of the bacterial and inorganic slime re-
accumulated on the surfaces of the RO membranes despite rou-
tine formalin sterilization, flushing, and rinsing procedures. It is
now considered that these PDS machines are not able to produce
water that is safe for dialysis in the face of the bacterial and endo-
toxin load present in the main water supply of the Johannesburg
Hospital, particularly after a layer of slime has been allowed to
accumulate on the outer surfaces of the RO membranes.
Thyroid function tests and the duration of regular hemodialysis.
C. H. Gold, W. J. Kalk, J. E. Morley, and A. Meyers. Endocri-
nology and Renal Units ofBaragwanath and Johannesburg Hos-
pitals. The effect of the duration of regular hemodialysis on thy-
roid function tests was studied in 101 patients. Immediately be-
fore the next period of dialysis, serum thyroxine (T4),
triiodothyronine (T3), thyrotrophin (TSH), and the T3 resin up-
take test were measured, and the free thyroxine index (FTI) was
calculated. In 50 patients, these measurements were repeated at
the end of the same period of dialysis. Serum T3 levels were sub-
normal in 32% of patients, and mean levels were not influenced
by the duration of dialysis. In all patients dialyzed for 3 months
or less, the FTI was normal. For the first 9 months of dialysis,
there was a significant linear fall in T4 and FF1. Thereafter, there
was a gradual further decline in mean T4 and FTI. TSH was not
influenced by the duration of dialysis. The prospective study
confirmed these findings. T3, T4, and TSH rose significantly after
dialysis, and values were normal in most subjects. in patients on
regular hemodialysis: (I) Thyroid function tests, particularly T3
levels, are frequently abnormally low, (2) there is a rapid fall in
T4 and FTI values in the first 9 to 12 months of dialysis, (3) T3, T4,
and FTI values rise during dialysis, often to normal levels, (4)
thyroid function in tests must be interpreted in relation to the last
period of dialysis and to the duration of dialysis.
Duration CA P04
yr (range) mEqiliter mg/IOU ml
12.8%, 74.4%, and 12.8%. The aims were, first, to assess the
factors that have resulted in a lower mortality rate, particular-
ly in a series where the percentage of surgical cases in group 2
was higher than it was in group 1, and hopefully thereby to im-
prove our results in the future. Thirty one males and 16 females
comprised group 2. The mean age was 43.2 years (range, 20 to
80). Hemodialysis of 4 to 6 hours was instituted daily in most
cases using an RSP and coil in all cases except one, where the
Rhodial and RP6 were used. Dialysate concentrations of potas-
sium and calcium were adjusted according to the patients' needs.
The treatment was aggressive, was started early, and was com-
bined in many cases with total parenteral nutrition (TPN), using
combinations of carbohydrates, fat, and amino acid infusions,
yielding 3000 calories and 10 to 12 g of nitrogen per day. The
mean number of HD treatments per patient was 9 (range, I to
33). The mean duration of CARF was 15 days (3 days to 9
weeks). Of 35 Sand O&G patients, 16 had sepsis. Vigorous anti-
biotic therapy was administered. Seven patients receiving TPN
died (26%), whereas 10 not on TPN died (50%). Of those who
lived, the mean duration of CARF in the TPN group was 22 days,
vs. 11 days in those without TPN. This was partly due to the fact
that only the sickest patients received TPN. The other factors
more commonly used in group 2 vs. group 1 were vigorous treat-
ment of respiratory failure, better control of bleeding problems,
and the availability of a highly trained team. The causes of death
were surgical sepsis (9), shock (I), medical causes (4), and bleed-
ing (3). Vigorous and early treatment of all these factors coupled
with TPN has reduced the mortality particularly in the surgical
group. Sepsis, however, remains a major cause of death.
Renal osteodystrophy in regular hemodialysis patients (RHD)
using softened or deionized water. G. Hudson, J. Mi/ne, P. Reis,
A. M. Meyers, and A. Hayward. Renal Unit, General Hospital,
Johannesburg, South Africa. Recent studies have suggested that
accelerated bone disease may occur in patients dialyzed on soft
water. Three RHD units, two on softened water and one on
deionized water, were studied. All patients had been dialyzed for
at least 1 year in a particular unit. Calcium (Ca), phosphorus
(P04), product (PD), and alkaline phosphatase (APase) were
measured serially for 1 year. The most recent skeletal surveys
were reviewed by three radiologists. The bone disease was grad-
ed as normal (1), hyperparathyroidism alone (II), osteomalacial
osteopenia (III), combination of renal osteodystrophy (IV), and
osteosclerosis alone (V). Unit A comprised 11 patients dialyzed
only on deionized water (7 M, 4 F; mean age, 41 years). Unit B,
softened water only, comprised 11 patients (7 M, 4 F; mean age,
43 years). Unit C, softened water, comprised 10 patients (4 M, 6
F; mean age, 48 years). There was no difference in mean hemo-
globin levels or number of anephric patients. Results (mean I
SD were:
Unit PD
APase
(30 to 100)
A 3.9 4.7 5.5 52.3 137 3xIV 2x1
(l.Sto9) 2x11 4xlII
B 3.4 5.1* 6.6* 68* 142 lxV IxI
(1.6) lxii 8x111
C 2.7 5.2* 6.6* 67.8* 148.6 3xI 7xffl
(1 to4) 191.9
Radiology
patients & grade
* <0.005 for B vs. A and C vs. A
Reduced mortality due to recent advances in treatment of acute
renal failure including medical, surgical, and gynecologic cases
(CARF).A. Hayward, P. Disler, andA. M. Meyers. Renal Unit,
Johannesburg General Hospital, South Africa. A retrospective
study of CARF was undertaken in patients treated by hemo-
dialysis (HD) at Johannesburg General Hospital from 1968 to
1973 (group I) and from 1975 to 1977 (group 2). Mortality in
group I was 61%; in group 2, 36%. The distribution of medical
(M), surgical (5), and obstetric (0&G) cases was as follows:
group 1, 32.6%, 54.4%, and 13%, respectively; and group 2,
Of the patients (19) who showed osteomalacialosteopenia, 11
were female. Of 5 patients, all from units B and C, who showed
severe radiologic and clinical osteomalacialosteopenia, 4 were
female. Twelve of the osteomalacia/osteopenia patients were
malnourished, with 5 being severely malnourished. Thus our re-
sults indicate that there is a marked increase of osteomalacia/
osteopenia in patients dialyzed on softened water. The disease
affects predominantly malnourished females. However, there is
also a significant increase in the Ca, P04 and PD levels in the soft
water units.
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High-dose frusemide in chronic renal failure. G. R. Keeton and
S. C. Morrison. University of Cape Town Department of Medi-
cine, Somerset Hospital, Green Point, Cape Town, South Af-
rica. It has been said that the use of high-dose frusemide in
chronic renal failure (CRF) may improve renal function. This
statement is based on short-term studies without an adequate
control period. The present trial was designed to define the ef-
fects of frusemide in CRF. Seven patients in stable chronic renal
failure, with a mean age of 54.4 years, were admitted to the Som-
erset Hospital. The creatinine clearance (Ccr) ranged from 3.2 to
22.8 mI/mm with a mean of 10.9 ml/min. For 10 days, fluid bal-
ance was carefully adjusted and no diuretics were given. During
the next 10 years, a gram orally of frusemide was given with
electrolyte replacement based on the 24-hour urine collections,
which were made throughout the 20 days. The mean values of
the treatment period showed urine volumes to be twice, and the
sodium output 2 to 12 times those of the control period. Potas-
sium excretion increased significantly in five patients. There was
no significant change in the following: Ccr, clearance urea, total
urea excretion, blood pressure, or serum sodium, potassium, or
osmolality. One gram of oral frusemide administered to patients
in stable CRF significantly increased urine volume and sodium
output, but renal function was unchanged. The increased urine
volume is nevertheless of value in making life more tolerable for
the patient in CRF.
Asymptomatic arsine nephrotoxicity. H. Levy, F. J. Milne, J.
R. Lewin, and D. T. Ninin. Departments of Medicine and Pa-
thology, University of the Witwatersrand, South Africa. Arsine,
one of the most toxic gases known, is formed by nascent hydro-
gen and arsenic. Arsine combines with hemoglobin, and hemol-
ysis results. The arsenic-hemoglobin complex is filtered by the
glomerulus, and renal damage occurs, theoretically on an anoxic
basis or due to hemoglobin casts. This results in oliguria and re-
nal failure unless vigorous treatment, involving dialysis and ex-
change transfusion, is instituted. Our patient was asymptomatic
2 weeks after exposure but had evidence of nephrotoxicity. He is
a 37-year-old chemical analyst who was exposed to rock samples
evolving arsine gas. He had no history of renal disease. On exam-
ination he was completely normal. A midstream urine specimen
showed proteinuria and hematuria. Hemoglobin was 14.2 g/lOO
ml with no evidence of hemolysis. Creatinine clearance was 62
ml/min on presentation and improved to 85 and 104 mI/mm over
the period of 1 month. An excretory urogram was normal. Renal
biopsy showed areas of acute tubular necrosis, including the
proximal convoluted tubules, patchy tubular atrophy, and areas
of regenerating tubular epithelium. Glomeruli were normal apart
from mild glomerular tamponade. Microprobe analysis failed to
show the presence of arsenic in tubular cells. These features are
consistent, however, with arsine nephrotoxicity. Due to this
asymptomatic presentation and possible direct nephrotoxicity,
we recommend routine urinalysis in at-risk occupations.
The differing histology in black and white children with the
nephrotic syndrome. J. R. Lewin, P. J. Jankowitz, and P. D.
Thomson. University of the Witwatersrand, South Africa. The
aim of this study was to compare renal biopsy histology of chil-
dren presenting with the nephrotic syndrome at a black hospital
(Baragwanath Hospital) with those at a white hospital (Transvaal
Memorial Hospital for Children) over the same 20-month period
(January 1977 to August 1978 inclusive). The indications for
biopsy were the same in both groups, namely, nephrotic syn-
drome with hypertension or macroscopic hematuna, steroid re-
sistance, frequent relapses, or steriod dependency where use of
cyclophosphamide was being considered. Routine histopathol-
ogy of paraffin sections were done on all the patients, together
with immunofluorescent and electron microscopic studies. There
were 15 blacks (11 males and 4 females) and 16 whites (7 males
and 9 females). The mean ages, in years, at presentation were as
follows: Total black group, 4.18 (so) 3.08; black males, 3.25
2.79; black females, 6.75 2.5; total white group, 5.55 4.44;
white males, 3.6 2.62; white females, 7.05 5.11. On com-
paring the total groups, and the males and females separately,
they were not significantly different, although it is of interest to
note that the black group was younger and that there were more
black males. Eight of the 15 black, and 7 of the 16 whites were
referred from outside the Johannesburg-Soweto area. Eight of
the blacks and 6 of the whites had hematuria. It was microscopic
in most, but 2 of the whites definitely had macroscopic hema-
turia. Three in each group were hypertensive. There was no evi-
dence of immune complex disease except in the "others" group.
The pathologic diagnosis is given in the following table:
Blacks 0 6 2 4 1 Membranous.
1 Foe. seg. prol.
1 Mem. prolif.
Whites 10 0 1 1 2 Mem. prolif.
I Membranous
1 Hered. neph.
With the populations in Johannesburg and Soweto being similar,
the striking result is the absence of minimal change in the black
group. This has also been found when comparing black and In-
dian children in Durban, and the logical conclusion is that mini-
mal change nephrotic syndrome in a black child is uncommon.
This should alter the management, and renal biopsy should be
indicated even in younger children, rather than a trial of steroids.
The changing face of primary hyperparathyroidism. M. G.
McGeown. Renal Unit, Belfast City Hospital. Biochemical
screening was introduced in Belfast on April 1, 1969. The unex-
pected discovery of hypercalcemia led to the diagnosis of 50 cases
of primary hyperparathyroidism. None of the patients had renal
stones or bone disease suggestive of hyperparathyroidism, al-
though two had Paget's disease and two had arthritis. During the
same period of time, 49 cases of hyperparathyroidism associated
with stone disease and 6 cases with hyperparathyroid bone dis-
ease were found. This is in marked contrast to a group of 176
patients with primary hyperparathyroidism diagnosed between
1954 and 1969, where 72% of the patients had renal stones, as
compared with 45% in the more recent group. The patients with
biochemical hyperparathyroidism" suffered from a wide varie-
ty of symptoms, the cardiovascular system being most common-
ly affected (14 patients) followed by the upper gastrointestinal
tract (9 patients). Hyperparathyroidism continues to affect fe-
males more commonly than it does males. Other causes of hyper-
calcemia uncovered by biochemical screening include myelo-
matosis (3 cases), hypernephroma (2 cases), sarcoidosis (2 cas-
es), anaplastic carcinoma with multiple bone secondaries (2
cases), lung neoplasm (1 case). The introduction of radioim-
munoassay for parathyroid hormone in October, 1976 was of
surprisingly little help in the differential diagnosis of hyper-
calcemia, as tumors are sometimes found in patients whose para-
thyroid hormone is not raised. It is still necessary to system-
atically exclude other causes of hypercalcemia and to be pre-
pared to explore the neck if no other cause is found.
Raised calcitonin (CT) in patients on regular dialysis (RDT):
"C" cell hyperplasia? A. M. Meyers, C. Dark, L. Laidley, G.
Hudson, F. J. Mime, and J. Lewin. Departments of Medicine
and Pathology, University of the Witwatersrand, South Africa.
The relation between the immunologic and biologic activity of
CT in blood, both in health and disease, is still largely unknown.
Similarly, a specific role of CT in either the pathogenesis or treat-
ment of renal bone disease (RBD) remains to be elucidated.
Thus, evidence of 'C" cell hyperplasia in patients with chronic
renal failure would help to determine a pathophysiologic role of
this hormone in RBD. Oral whiskey has been shown to be a po-
tent stimulus of CT secretion, with peak increments at 15 to 30
mm after ingestion. Eighteen patients on RD and 18 controls
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were given 50 ml of whiskey after an overnight fast. Blood was
drawn at times, 0, 5, 15, 30, 60, 120, and 180 mm after ingestion
and were frozen and stored. After completion of the study, the
whole batch was run, and duplicate estimations of CT and gastrin
were measured using previously described and carefully stan-
dardized radioimmunoassay techniques. The results were com-
pared with clinical and radiologic evidence of bone disease, bio-
chemical abnormalities (Ca, P. Alk. phos.), and PTH levels.
Mean basal control CT was 0.28 0.08 mg/mI, mean basal pa-
tient CT was 0.58 0.16 mg/ml. Maximum peak controls at 15
mm were 0.61 0.2, and in patients at 60 mm they were 1.1
(±0.1). Nine patients, 4 of whom had previously undergone sub-
total parathyroidectomy, demonstrated completely normal basal
and stimulated curves. The levels of the 9 remaining abnormal
patients were as follows: basal, 0.72 0.22; maximal (at 90 mm),
2.52 0.49. In the patient group, no statistical correlation be-
tween CT and total calcium levels was shown. There was no sta-
tistical significance between basal CT levels and iPTH, but a
highly significant direct correlation between maximal CT levels
and PTH (P < 0.05) was demonstrated. Of the 9 patients with
abnormal stimulation, I had normal bones, 1 had osteomalacia
only, and 7 had obvious hyperparathyroidism. Of the 9 normal
patients, only 1 had skeletal evidence of hyperparathyroidism.
Two of these patients underwent subsequent parathyroidec-
tomy, and, on electromicroscopy, "C' cell hyperplasia was
demonstrated in upper lobe thyroid biopsy specimens. It is
concluded that the alcohol-stimulated CT test is useful in detect-
ing patients on RDT with "tertiary" hyperparathyroidism and
that 'C" cell hyperplasia often exists in these patients. How-
ever, 50% of the patient group had normal basal and stimulation
levels, which included 4 who had undergone previous para-
thyroidectomies.
Rheumatoid arthritis (RA) and glomerulonephritis (GN). A. M.
Meyers, J. Lewin, P. Kraut, J. Cohen, and F. J. Mime. Renal
Unit, Department of Medicine, Medical School, Johannesburg,
South Africa. Mild segmental proliferative GN, interstitial ne-
phritis, amyloid and analgesic nephropathy are well-known com-
plications of RA. One case of mesangio-capillary GN has been
described well, and a few sporadic cases of GN have been men-
tioned in the literature but not described. We report here four
cases of classical RA and various forms of GN. Clinical records
were assessed and all four patients underwent renal biopsies
which were prepared for light microscopy, immunofluorescence,
and electron microscopy. An outline of the results are shown in
Tables 1 and 2.
Table 1. Clinical data.
Symptoms Dur. Renal
Pt. Age Sex RA yr Pres. Other
1 68 M Classical;
deforming
2 67 F Classical;
deforming
3 31 F Classical;
deforming
4 64 F Classical;
deforming
tARF = acute renal failure; ttNS = nephrotic syndrome
Antinuclear factor. Anti-DNA antibodies, cryoglobulins, and a
wide variety of other autoantibodies were not found. All four
patients had varying degrees of diffuse interstitial infiltrate in the
renal biopsies, and patient no. 2 had two vasculitic areas. Leg
vasculitis was present in patient no. 3. Sicca syndrome was pres-
ent in patients no. 2 (symptomatic) and no. 4 (asymptomatic). It
is stressed that these patients had classical RA and not Sjdgren's
syndrome alone, which is a different entity and where three cases
of RPGN have been recently described. HLA B8 was not present
Table 2. Serology and biopsies.
CreatininePro- — Tr. and
Pt. RhF C 3/4 teinuria Pre Tr. Post Tr. results Biopsy
1 '/128 N + 4.0 1.8 St; well SPGN
4+ 14 — St+I; died
4+ 1.3 1.2 St; well
4+ 7.8 2.4 St; well
PGN = proliferative glomerulonephritis; S = segmental; M =
membrano; RP = Rapidly progressive (>60% crescents); CR =
crescents; ST = steroids; I = immunosuppressives; Tr = treat-
ment.
in two of four patients tested. Thus four patients with classical
but complicated RA presented with AGN, three had crescents,
and one had pure MPGN. Steroids were of value in three of the
four patients. It is concluded that the association may be more
common than it is presently recognized.
Dialysis cardiomyopathy: A pathologic entity? F. J. Milne, J.
Lewin, P. M. Poulos, A. M. Meyers, and C. Chatgidakis. Renal
Unit and Department of Pathology, University of the Witwaters-
rand, Johannesburg, South Africa. The existence of a clinical
dialysis (uremic) cardiomyopathy is controversial, and it is
claimed that hemodialysis patients (RHD) have an increased
death rate from myocardial infarction (MI). We retrospectively
reviewed all our postmortem data (PM) on patients over 25 years
who died more than 3 years after RHD or transplantation (TP).
On starting treatment, none of these patients had clinical evi-
dence of severe coronary artery disease. The records of 20 such
patients and 12 controls (C), which included 5 with chronic renal
failure and 7 who died within 12 months of starting RHD and/or 3
months of TP, were studied. The same pathologist performed 21
of the 32 PM's. The PM sheets were reviewed for cause of death,
degree of coronary atheroma (0 to 5), and the microscopic myo-
cardial findings. The sections were reassessed for evidence of
infarction, fibrosis, small vessel disease (PAS strain), iron
(Perl's), and calcification (van Kossa's). Results (mean and the
range) were:
RHD
(N=9) 44
(27 to 57)
TP
C
Myocardial
fibrosis
No. of
patients %
(N= 12) 50.5 8M:4F <15 1.7
(43 to 57) (Oto3) +1 MI
The results show that no RHD died of MI and they had less coro-
nary atheroma than did TP or C. However, 67% RHD had evi-
dence of variably diffuse (I to 4+) myocardial fibrosis. In one
RHD and one TP, the fibrosis was associated with calcification,
but none showed small vessel disease or iron overload. This
study in no way suggests what factors may be responsible for our
dialysis cardiomyopathy.
Suppressor cell function in systemic lupus erythematosis (SLE).
B. Newman, S. Blank, R. Lomnitzer, P. Disler, and A. R. Rab-
son. Department of L'nmunology, School of Pathology of the
University of the Witwatersrand and the South African Institute
for Medical Research, and Department of Medicine and Renal
2 1/64
3 +ve
4 '/is
N
N
N
+Cr.
RPSPGN
MPGN
RPSPGN
Age
Group yr
8 Hypt.,
Prot.
17 ARFt
Coronary
atheroma
(mean R+L)
Duration
Sex treatment
ratio months
4M:5F 53.5
(36 to 80)
Lung infiltrate
Sicca Synd.
4 NStt Vasculitis
8 ARF Polyserositis
(N= 11) 46 7M:4F 67.7
(26 to 59) (45 to 95)
0.4 6
(Otol.5) OMI
1.8 3
(Oto4) +1MI
67
30
9
90 Abstracts
Unit, Johannesburg General Hospital, University of the Witwa-
tersrand. A specific subpopulation of thymus-dependent (T) cells
has been described which is capable of regulating or modulating
bone-marrow-dependent (B) lymphocytes by suppressing their
capacity to form antibodies or secrete immunoglobulins. The
function of these suppressor cells is impaired in New Zealand
black (NZB) mice which develop autoimmune phenomena re-
sembling human SLE, and it was therefore of interest to examine
suppressor cell function in patients with active SLE. Mono-
nuclear cells (MN) from 12 patients and numerous controls were
treated with Concanavalin A (Con A) for 72 hours to induce sup-
pressor cells, which were then assayed by assessing their sup-
pressive effect on normal lymphocytes transformed with either
PHA (20 g) or Con A (10 pg). Normal control MN treated with
Con A consistently suppressed H-thymidine uptake (40 to 67%;
mean, 55%). Of the 12 SLE patients, MN from 5 failed to pro-
duce normal suppressive activity. No clinical distinction could
be made between the group who lacked suppressor cells and
those with normal lymphocyte function as assessed by disease
activity, complement levels, prior steroid therapy, presence of
renal failure, or other complications. The serum of patients with
SLE failed to inhibit the production of suppressor cells by normal
Con A-treated MN. The absence of Con A inducible suppressor
cells in some patients with SLE may be responsible for failure of
B cell regulation, thereby allowing the emergence of autoreactive
clones.
Dialysis encephalopathy: Aluminum concentration in dialysate
and brain. M. D. Pascoe and M. C. Gregory. Renal Unit, Groote
Schuur Hospital, Observatory, Cape, South Africa. Because of
the frequency of the dialysis encephalopathy syndrome in our
unit, and the possible relation of high water aluminum to this
syndrome, we undertook a study to determine aluminum concen-
tration. Atomic absorbtion spectroscopy was used with a graph-
ite furnace and argon purge. The method of standard additions
was used for serum and dialysate. Raw tap water had aluminum
concentration of 280 to 300 gIliter, soft water concentration
used in dialysate preparation of 220 gIliter, and dialysate of 250
pg/liter. Serum levels ranged from 107 to 411 gIliter to dialysis
patients. Brain aluminum was essentially the same in normal
controls and patients with dialysis encephalopathy. High levels
of serum aluminum were found in dialysis patients. There were
insufficient results to show a significant difference between en-
cephalopathic and nonencephalopathic dialysis patients, al-
though results in the former tended to be higher.
Effects of oral isoniazid on human lymphocytes. F. H. Pauw.
Niereenheid, Renal Unit, Universitas Hospital, Bloemfontein.
The significance of vitamin B6 for intact immune function was
recognized more than 30 years ago. Isoniazid (INH) the com-
monly used antituberculous drug is an antagonist of vitamin B6
metabolism. In a pilot study, an experimental person had a
marked reduction of T lymphocytes in his peripheral blood after
the administration of INH in high dosage. The present experi-
ment was designed to determine whether statistically significant
changes in lymphocyte subpopulations would occur after INH
administration. INH (600 to 900 mg) was given by mouth daily
for 6 days to 6 volunteers. Regular determinations of T cells, B
cells, and null cells in peripheral blood were done before, during,
and after the course of INH. Results were subjected to the t test
for paired observations and the t test for significant regression
over the period of INH administration. Forty eight hours after
the first dose of INH, a statistically significant reduction in T
lymphocyte numbers was noted (P < 0.05). This decrease in T
cells continued over the period of INH administration (P < 0.01).
After discontinuing INH, a significant increase in T cells was
noted (P < 0.05). B lymphocytes increased significantly during
INH administration (P < 0.05] and decreased significantly after
discontinuing INH (P < 0.05). Total lymphocyte counts and null
cells did not change significantly. Side effects were common
though not serious. Conclusion. INH administration resulted in a
decrease in peripheral blood T lymphocyte numbers without a
concomitant decrease in B lymphocytes. Since T cells are partic-
ularly important in transplant rejection, INH seems a promising
drug for use as an immunosuppressant in organ transplantation.
Blood volume expansion: Relationship between natriuresis and
filtration fraction. D. Querido and L. C. Isaacson. Department of
Physiology, Medical School, University of Cape Town, South
Africa. We have attempted to demonstrate the appearance, and
intrarenal mode of action, of a circulating natriuretic factor after
acute volume expansion with equilibrated whole blood. A donor
kidney was placed in an extracorporeal circulation (constant-
pressure arterial pump, venous reservoir, and venous-return
pump) of a recipient rat, without interruption of its blood supply.
In 12 such experiments, volume expansion was induced after 63
II mm, by infusion of 1.5 or 2.8 ml of reservoir blood per 100 g
of body wt. A further 6 experiments served as controls. During
the 30 mm before, and the 40 mm after volume expansion (means
su):
RBF, mlmin' 6.0 2.0 7.0 2.5 <0.01
C1,mlmin 0.61 0.37 0.52 0.29 <0.01
Filtr.fract. 0.19 0.10 0.15 0.09 <0.005
UNaV, jmolmin1 1.84 2.79 2.50 4.07 NS
FENa 0.29 0.32 0.45 0.56 <0.05
(I — FENa)1 varied linearly with (filtr. fract.)1 (r = 0.86 0.16).
The 6 controls displayed no significant contemporaneous dif-
ferences. Thus, volume expansion produced natriuresis, second-
ary to a humorally-mediated fall in filtration fraction.
Acute renal failure among the Africans and Indians in South
Africa. Y. K. Seedat. Renal Unit, Department of Medicine, Uni-
versity of Natal and King Edward VIII Hospital, Durban, South
Africa. Acute renal failure (ARF) is a common problem in tropi-
cal Africa because of the high incidence of infections and herbal
intoxication. One hundred and fifty patients who remained oh-
guric after adequate hydration and following the administration
of furosemide were studied. The relevant biochemical investiga-
tions, chest X-ray, and ECG were done. Of the 150 patients 97
(65%) developed ARF from a medical cause, and the two most
common causes were nephrotoxins (35%) and infections (22%).
The widespread use of traditional herbal medicines was par-
ticularly hazardous. Infections of viral or bacterial origin, schis-
tosomiasis, and malaria were particularly important. The most
common gynaecologic cause of ARF was self-induced abortion.
The overall mortality was 35%. Although finance costs may pro-
hibit the establishment of renal units in many parts of Africa
for the treatment of chronic renal failure, ARF may be easily
treated.
Nephrotic syndrome in the Africans and Indians of South Af-
rica: A 10-year study. Y. K. Seedat. Renal Unit, Department of
Medicine, University of Natal and King Edward VIII Hospital,
Durban, South Africa. This study was undertaken to study the
nephrotic syndrome in a malaria-free part of Africa. A prospec-
tive study of 180 adult nephrotic patients was begun in 1966 and
ended in 1976, and the clinical, biochemical, and renal histologic
changes were studied. The frequency of nephrotic syndrome was
0.2% of all medical admission records. The majority of the pa-
tients were between the ages of 12 and 30 years. The etiology of
the nephrotic syndrome was determined in 94% of the African
patients and 87% of the Indian patients. The most common histo-
logic pattern in both racial groups was proliferative glomerulone-
phritis followed by membranous glomerulonephritis. Minimal
change nephropathy on light microscopy was rare. The incidence
of nephrotic syndrome is lower compared with areas like West
Africa and East Africa where quartan malaria is common. Be-
cause of the rarity of the minimal change group on light micros-
copy, an important therapeutic aspect is that African patients
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suffering from nephrotic syndrome will not as a rule respond to
steroids of cyclophosphamide therapy.
The prevalence, etiology, and complications of hypertension in
the South African black population. Y. K. Seedat. Rena! Unit,
Department of Medicine, University of Natal and King Edward
VIII Hospital, Durban, South Africa. This study was done to
determine the prevalence and etiologic factors of hypertension in
the urban Zulu. The complications of hypertension as seen in the
hospitalized patient and at autopsy were elucidated. The preva-
lence and etiologic factors of hypertension were done in a ran-
dom house-to-house study of 1,000 urban Zulu subjects. The
complications of hypertension were studied over a period of 10
years in 500 black subjects suffering from hypertension at King
Edward VIII Hospital. The autopsy data of 434 patients seen
over a period of 10 years were studied. The prevalence of essen-
tial hypertension using the WHO criteria was 25% (females 27%,
males 27%). The prevalence percentage by age and sex showed
that females between the ages of 35 and 40 years had a higher
prevalence compared to males. The etiologic factors for the hy-
pertension were obesity, acculturation, and possibly excessive
salt intake. The main complications of hypertension were those
of cerebrovascular episode (mainly in the form of cerebral hem-
orrhage), congestive cardiac failure, and uremia. The absence of
ischemic heart disease even though they developed congestive
cardiac failure was noted. It appears that hypertension is an
emerging disease in the urbanized African, which is increasing in
incidence.
Somatostatin and the kidney: Its presence in normal urine, renal
arteriovenous gradient in the rat, and metabolic clearance in nor-
mal subjects and in end-stage renal failure. M. Sheppard, B. Sha-
piro, M. Gregory, S. Kronheim, and B. Pi,nstone. Isotope and
Immunoassay Laboratory, Department of Medicine, University
of Cape Town and Renal Service, Groote Schuur Hospital,
South Africa. The role of the kidney in the handling of endoge-
nous and exogenously administered somatostatin has not yet
been investigated. This laboratory has demonstrated the pres-
ence of somatostatin-like immunoreactivity in normal human
urine and a renal arteriovenous somatostatin gradient in the rat.
This study reports the metabolic clearance and plasma P12 dis-
appearance of exogenous somatostatin in normal subjects and in
patients with end-stage renal failure. Synthetic, highly purified
somatostatin (Ayerst 24910) was given over 30 mm by constant
infusion to 7 normal subjects and 5 patients with chronic end-
stage renal failure 66 to 68 hours after regular dialysis. The dose
given was adjusted to achieve steady-state concentrations of
plasma somatostatin (RIA). Metabolic clearance rate (MCR) was
calculated from these concentrations and the rate of infusion.
TV2 was calculated after abrupt cessation of infusion. The mean
SEM MCR in normal subjects was 1949 250 mI/mm (28.5
4.2 mI/mm/kg). In patients with renal failure, the MCR was
501 33 mI/mm (7.8 0.6 mllmin/kg). T>/2 ranged from 1.1 to
3.0 mm in normal subjects and from 2.6 to 4.9 mm in renal fail-
ure. Exogenously administered somatostatin has a rapid meta-
bolic clearance and short plasma t1/2 disappearance in man, in
keeping with its role as a neuromodulator. In end-stage renal
failure, a substantial drop in MCR occurs: a possible explanation
is impaired degradation at nonrenal sites as a complication of
the uremic state.
C-Reactive protein in renal allograft rejection. R. Van Zyl Smit,
and P. Camacho. Renal Unit, Groote Schuur Hospital, Observa-
tory Cape Town, South Africa. The diagnosis of renal allograft
rejection is often extremely difficult, especially if the kidney is
not functioning, presumably due to early acute tubular necrosis.
Here one is not able to judge whether allergic damage is occur-
ring by assessing changes in renal function. In this situation in-
vestigations such as the isotope renogram, body temperature,
renal biopsy, etc., are often of limited value. The value of daily
serum C-reactive protein (CRP) estimation has been assessed, as
it is well known that CR1> rises dramatically in most instances
where inflammatory tissue damage is occurring. Samples were
taken and stored at —20° C until time of assay by a radial immu-
nodiffusion technique. Levels are expressed as ngml. The
stimulus of the surgery involved with renal transplantation
causes a rise in CRP (mean, 120 (so) 54 mglml1, N = 18),
which subsides within 4 to 5 days (less than 10 mg/ml1). After
this period, rises in CRP were all associated with either rejection,
infection, ureteric obstruction, or surgery for posttransplant
complications. In the absence of the latter three, rejection was
assumed, which corresponded well with assessment on other cri-
teria such as clinical state, rising creatinine, renal biopsy, etc. In
cases of clear-cut rejection, the mean CRP rise was 158
80 mg/ml' (N = 10). In seven cases with presumed ATN and no
obvious other complications and or rejection, three had CRP of
10 mWml. The other four were all below 20 mg/ml (mean, 15
mg/mI—'). In cases with complications such as infection, ureteric
leaks, etc., the problem was too complicated and CRP levels dif-
ficult to interpret. Serial CRP estimations form a valuable ad-
junct to the assessment of patients with possible renal allograft
rejection in the presence of a nonfunctioning kidney and in the
absence of multiple complications.
Postpartum nephrosclerosis. Y. Veriava, J. D. Cohen, W. D.
Chin, and J. Lewin. Coronation Hospital, Private Bag, New-
dare, South Africa. Of the 29 cases of irreversible postpartum
renal failure reported in the literature, 18 died. In only 7 patients
did renal function improve to a creatinine clearance greater than
10 mI/mm. Recovery in 8 patients was attributed to the use of
anticoagulant therapy. A 27-year-old nurse, para 1 gravida 2,
who was normal up to 36 weeks gestation, went into labor and
delivered a macerated fetus. Two weeks later, she was markedly
anemic and dyspneic, with a trace of pedal edema and oliguria.
Her blood pressure was elevated to 170/110. Her urine contained
2+ protein with granular casts, 14,000 WBC/mm3, 43,000 RBC/
mm3. Her hemoglobin was 5.8/100 ml, white cell count 7,100mm3,
reticulocytes 23% with fragmentation of red cells. The plate-
let count had fallen to 60,000/mm3. Serum urea was elevated
to 236 mg/l00 ml and creatinine to 14 mg/l00 ml. The direct and
indirect Coombs test, Schuums test, and test for ANF were neg-
ative. The antistreptolysin titer, serum complement (C3 and C4),
serum protein electrophoresis, fibrinogen degradation products,
partial thromoboplastin time, and the prothrombin index were all
normal. Serum haptoglobin level was low, 22 mg/100 ml. Therapy
consisted of a 48-hour peritoneal dialysis, blood transfusion, and
antihypertensive therapy. Renal function improved following
dialysis and antihypertensive therapy with an increase in urine
output and a fall in serum creatinine. Renal function stabilized at
a serum creatinine of 1.4 mg/lOO ml. Renal biopsy showed is-
chemic glomeruli and hyperplastic intimal lesions of the vessels
with complete obliteration of the lumen. The etiology of idio-
pathic postpartum renal failure or postpartum nephrosclerosis
remains obscure. It is of interest that this patient has had a milder
course than most other reported cases and showed considerable
improvement without the use of anticoagulant therapy.
